Sadly, some of the strongest characters that stand out in the books didn't make it into any of the Harry Potter movies.

Catalyst Pharmaceuticals settles patent litigation with Teva, delaying generic Firdapse launch until 2035. Legal actions against other defendants remain ongoing.

H.C. Wainwright analyst Andrew Fein raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $35 from $30 and keeps a Buy rating on ...

The Harry Potter series is getting adapted all over again, and there are plenty of things it should do differently this time. By expanding from about one movie per book into perhaps more than a season ...

Harry Potter introduced viewers to a world of wizards, spells, and fantastical creatures. Based on a book series of the same ...

Squid Game Season 2 made its highly anticipated premiere with Netflix earlier this week, and it’s already breaking all sorts of records with the streamer in its first few days alone. Squid Game was ...

More than 2,800 Texans are getting abortion pills through the mail from out-of-state every month, prompting a lawsuit and ...

Stocks like Rail Vikas Nigam, CESC, Dhanlaxmi Bank, Jubilant Ingrevia, Adani Green Energy, Archean Chemical Industries, Century Enka, Bank of India, Prataap Snacks, Power Grid Corporation of India, ...

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for ...

The quiz, presented by Slurrp, began in October with all-India online preliminary rounds, attracting more than 22,000 student registrations Mumbai: The national final round of Lupin Aptivate ...

The stake sale is being conducted through an accelerated book-building process ... in the US markets. Lupin is one of the first ANDA applicants and is eligible for 180 days of shared generic ...